Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/1999
01/20/1999EP0689428B1 Enhanced circulation effector composition and method
01/20/1999EP0632693B1 Biological control of post-harvest diseases
01/20/1999EP0630245B1 Protein kinase c inhibitor
01/20/1999EP0630242B1 Further indole derivatives with antiviral activity
01/20/1999CN1205706A Novel cephalosporin derivatives and processes for prepn. thereof
01/20/1999CN1205636A Injectable quinolone formulations
01/20/1999CN1041731C Pyrido [1,2,3-d,3)(1,3,4) benzoxadiazine derivatives
01/19/1999US5861518 Phthalide compounds and their production process
01/19/1999US5861512 Reaction of 2-tert-butylcarboxamidepiperazine with acid in solvent, heating, dissolving, cooling, precipitation of crystals
01/19/1999US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases
01/19/1999US5861508 Purification of a cephalosporin salt
01/19/1999US5861501 Capped synthetic RNA, analogs, and aptamers
01/19/1999US5861493 Process for the synthesis of 2'-O-substituted pyrimidines
01/19/1999US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity
01/19/1999US5861436 Inhibitors of the relese of tumor necrosis factor
01/19/1999US5861429 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests
01/19/1999US5861426 Nitro esters of aromatic compounds with amide or ester groups
01/19/1999US5861413 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
01/19/1999US5861402 1,4-dihydropyridine compounds
01/19/1999US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria
01/19/1999US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes
01/19/1999US5861313 Method of isolating bile duct progenitor cells
01/19/1999US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
01/19/1999US5861282 Mutant constructs; vaccines; genetic engineering
01/19/1999US5861281 Lacc
01/19/1999US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same
01/19/1999US5861243 Amino acid sequences
01/19/1999US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto
01/19/1999US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions
01/19/1999US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response
01/19/1999US5861141 Pharmaceutical formulations of cefaclor
01/19/1999CA2179987C Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
01/19/1999CA2168865C Antiviral thiazoles
01/19/1999CA2131231C Salmonella live vaccine
01/19/1999CA2108455C Pharmaceutical compositions against gastric disorders
01/19/1999CA2105382C Recombinant hybrid porin epitopes
01/19/1999CA2089005C Method for inactivating pathogens in a body fluid
01/19/1999CA2037663C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in the obtaining of anti-ulcer drugs, new complexes and chelates resp., of antibiotics with bivalent and/trivalent metals and processes for the obtaining thereof
01/19/1999CA2002105C Dideoxy-l-arabinitol derivatives as antiviral compounds
01/18/1999US6015565 Polynucleotides with sequences
01/18/1999CA2237160A1 Gida1
01/18/1999CA2237147A1 Novel ratb
01/18/1999CA2237143A1 Novel rata
01/18/1999CA2237140A1 Novel tarf
01/18/1999CA2237050A1 Histidine kinase
01/18/1999CA2237043A1 Response regulator
01/14/1999WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family
01/14/1999WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
01/14/1999WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
01/14/1999WO1999001498A1 Conjugate of polyethylene glycol and chitosan
01/14/1999WO1999001473A2 Anti-bacterial methods and materials
01/14/1999WO1999001472A1 Cyclic azapeptides with angiogenic effect
01/14/1999WO1999001466A1 Secreted proteins and polynucleotides encoding them
01/14/1999WO1999001464A1 Componds and methods for treating and screening viral reactivation
01/14/1999WO1999001452A1 Novel cycloalkyl substituted imidazoles
01/14/1999WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/14/1999WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
01/14/1999WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists
01/14/1999WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999WO1999001136A1 Novel substituted imidazole compounds
01/14/1999WO1999001131A1 Novel substituted imidazole compounds
01/14/1999WO1999001130A1 Novel substituted imidazole compounds
01/14/1999WO1999001127A1 Compounds and methods
01/14/1999WO1999001117A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins
01/14/1999WO1998050555A3 Enterococcus faecalis polynucleotides and polypeptides
01/14/1999WO1998049315A3 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
01/14/1999WO1998045276A3 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
01/14/1999WO1998038986A3 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections
01/14/1999WO1998038212A3 Chimeric polypeptides containing chemokine domains
01/14/1999WO1998034917A3 Synthesis of acyclic nucleoside derivatives
01/14/1999DE19729810A1 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung Means for sepsis therapy, its preparation and its use
01/14/1999CA2297181A1 Cyclic azapeptides
01/14/1999CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
01/14/1999CA2295933A1 Compounds and methods for treating and screening viral reactivation
01/14/1999CA2295762A1 Novel cycloalkyl substituted imidazoles
01/14/1999CA2295376A1 Anti-bacterial methods and materials
01/14/1999CA2295294A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999CA2295228A1 Novel substituted imidazole compounds
01/14/1999CA2295212A1 Secreted proteins and polynucleotides encoding them
01/14/1999CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
01/14/1999CA2294770A1 Compounds and methods
01/14/1999CA2294764A1 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins
01/14/1999CA2294524A1 Novel substituted imidazole compounds
01/14/1999CA2294522A1 Novel substituted imidazole compounds
01/14/1999CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/14/1999CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family
01/13/1999EP0890647A2 PcrA, novel polypeptide of the DNA helicases family
01/13/1999EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase
01/13/1999EP0890642A2 Retrovirus of the HIV-group and its application
01/13/1999EP0890641A1 Novel IspA
01/13/1999EP0890571A1 Process for the preparation of(1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
01/13/1999EP0889955A1 Recombinant phages
01/13/1999EP0889903A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
01/13/1999EP0889902A1 Antibiotic peptides from bovine milk
01/13/1999EP0889888A1 Novel treatment for cns injuries
01/13/1999EP0889887A1 Novel treatment for cns injuries
01/13/1999EP0889881A1 New triazoles as therapeutic agents for fungal infections
01/13/1999EP0889878A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
01/13/1999EP0889690A1 Antibiotic cocktail and method of use
01/13/1999CN1204497A Natural eyebrow streaking method and natural colour eyebrow streaking liquid used in said method